U.S. CLINICAL NUTRITION MARKET ANALYSIS

U.S. Clinical Nutrition Market, By Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition) and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals and Others (Fibers, etc.)), By Form (Powder, Liquid and Others (Solid,etc.)), By Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, Ambulatory Surgical Centers and Others (Research Institutes, etc.))

Published In : Sep 2023
Code : CMI4412
Pages :154
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

U.S. Clinical Nutrition Market: Key Developments

On January 25, 2023, Nutricia, a subsidiary of Danone, a global multinational food-products manufacturing corporation, announced the launch of Fortimel, a plant-based oral nutritional supplement made from pea and soy protein that meets dietary needs of malnourished patients and those at risk of becoming malnourished
In February 2022, Kate Farms, a U.S. based company that provides plant-based shakes and formulas, announced the launch of its newest shake, Glucose Support 1.2. This first-of-its-kind plant-based, organic nutrition shake is designed to manage blood sugar as part of a balanced diet. As the newest addition to the Kate Farms nutrition portfolio, Glucose Support 1.2 is created to deliver plant-based nutrition to patients living with diabetes.
In August 2020, Otsuka Pharmaceutical Co., Ltd, a global pharmaceutical company, announced the launch of Enoras liquid, a nutritional product that is indicated to maintain the daily amount of vitamins and trace elements in the individuals and post-operative patients. Enoras liquid can be administered through a feeding tube, and can be consumed through mouth by individuals.
In June 2020, Arla Foods Ingredients, a global whey ingredient supplier, launched a new whey protein ingredient Lacprodan HYDRO.Rebuild that is clinically proven to counteract age-related muscle mass decline. It offers highly accessible content of branched-chain amino acids and essential amino acids such as leucine that are important for muscle synthesis in seniors, and also helps in improving the muscle mass, strength, and mobility.

U.S. Clinical Nutrition Market Report Snapshots